期刊文献+

尿激酶型纤溶酶原激活物及其受体表达与胰腺癌浸润和转移的关系 被引量:5

THE EXPRESSION OF uPA AND uPAR AND ITS RELATION WITH INVASION AS WELL AS METASTASIS OF PANCREATIC CANCER
下载PDF
导出
摘要 ①目的 探讨尿激酶型纤溶酶原激活物 (uPA)与其特异性受体 (uPAR)在胰腺癌组织表达及与胰腺癌浸润和转移的关系。②方法 应用免疫组织化学PicTureTM法检测 8例正常胰腺和 4 7例胰腺癌组织中uPA和uPAR的表达。③结果 正常胰腺组织中uPA和uPAR均呈阴性表达 ,而胰腺癌组织中uPA和uPAR表达阳性率分别为5 7.4 % (2 7/47)和 5 1.1% (2 4 /47) ;二者与胰腺癌的浸润 (χ2 =5 .35、5 .0 0 ,P <0 .0 5 )和转移 (χ2 =7.5 2、6 .13,P <0 .0 5 )密切相关 ,而与胰腺癌的组织学分级无关 (χ2 =2 .5 3、2 .84 ,P >0 .0 5 ) ;uPA与uPAR表达呈显著正相关 (r =0 .86 ,χ2=10 .2 3,P <0 .0 1)。④结论 uPA uPAR系统的激活在胰腺癌浸润和转移过程中起重要作用。 Objective\ To study the expression of urokinase type plasminogen activator (uPA) and uPA receptor (uPAR) and investigate its relation with invasion and metastasis in pancreatic carcinoma. \ Methods\ uPA and uPAR in tissues of 47 cases of pancreatic carcinoma and eight normal pancreas were examined by immunohistochemical method. \ Results\ uPA and uPAR were negative in tissue of eight normal pancreas. The positive rates of uPA and uPAR in 47 cancer tissue were 57.4% and 51.1%, respectively, both were closely correlated with invasion ( χ 2=5.35,5.00,P <0.05) and metastasis ( χ 2=7.52,6.13,P <0.05),but no relation with histological grading noted ( χ 2=2.53,2.84,P >0.05). The expression of uPA was positively correlated with that of uPAR in pancreatic cancer ( r=0.86,χ 2=10.23,P <0.01). \ Conclusion\ The activation of uPA uPAR plays an important role in the process of invasion and metastasis of pancreatic carcinoma.
出处 《青岛大学医学院学报》 CAS 2003年第3期244-245,共2页 Acta Academiae Medicinae Qingdao Universitatis
关键词 胰腺癌 尿激酶型纤溶酶原激活物 特异性受体 肿瘤浸润 肿瘤转移 pancreatic carcinomas urokinase receptor, urokinase immunohistochemistry
  • 相关文献

参考文献5

  • 1[1]Bruckner A, Filderman AE, Kirchheimer JC, et al. Endogenous receptor bound urokinase mediates tissue invasion of the human lung carcinoma cell lines A549 and Calu-Ⅰ[J]. Cancer Res, 1992,52(11):3043.
  • 2[2]Reuning U, Magdolen V, Wilhelm O, et al. Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis (review)[J]. Int J Oncol,1998,13(5):893.
  • 3[3]Cantero D, Friess H, Zimmermann A, et al. Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma[J]. Br J Cancer,1997,75(3):388.
  • 4[4]Yang JL, Seetoo D, Wang Y, et al. Urokinase-type plasminogen activator and receptor in colorectal cancer: independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targets[J]. Int J Cancer, 2000, 89(5):431.
  • 5[5]Foekens JA, Peters HA, Look MP, et al . The urokinase system of plasminogen activation and prognosis in 2 780 breast cancer patients[J]. Cancer Res,2000,60(3):636.

同被引文献70

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部